Silo Pharma, Inc.

Analysis for Ticker: SILO

Silo Pharma Inc focuses on treatments for the central nervous system, including medical research into Alzheimer's disease, chronic pain, and psychedelic solutions for stress disorders. The fundamental reality of this company is one math problem that has already been solved by the people running it. By 12/2025, they managed to pull in exactly 72.102$ in revenue from one license, but they spent 4,3$ million on operating costs. To one child, this looks like a toy box where you throw away four dollars every time you find seven cents; eventually, the box is empty unless you keep tricking others into putting money in. The company is not a pharmacy; it is a printer that creates new shares of stock to pay for its own survival while the value of what people already own is ground down to nothing.